Authors


Sandra Kear, OncLive

Latest:

Practice-Changing Data Revealed for Premenopausal HR+ Breast Cancer

Findings presented at 50th Annual Meeting of ASCO show aromatase inhibitor effective for premenopausal women when combined with ovarian function suppression.


Ellen Whipple, BSPharm, PharmD

Latest:

Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist's Role in Advancing Patient Care

This Continuing Education activity is supported by educational grants from Sanofi-Aventis US Genzyme and Novartis Pharmaceuticals Corporation.


Stephanie Sharkey, PharmD Candidate

Latest:

Detecting Signs of Opioid Abuse and Treating the Addiction

Knowing the warning signs and establishing trust are crucial to identifying and treating the opioid abuser.


Joseph Barone, PharmD

Latest:

Systemic Therapy Options for Treating HR+/HER2– Metastatic Breast Cancer

Following initial breast cancer diagnosis by mammography, MRI, or ultrasound, treatment is largely based upon the histologic subtype and staging of the tumor(s).


Alla Stavnitser, BS

Latest:

Trends in Statin Treatment Costs and Potential Impact of Novel Therapies

Generic atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.


Melanie Smith, PharmD, BCPS

Latest:

Fostering Rapid Innovation During a Time of Crisis

Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.




Robert LoNigro, MD

Latest:

Implications of STeP for Improved Diabetes Control: A Payer Perspective

Implementation of the STeP program across managed care organizations could lead to improved patient outcomes and significant cost savings.


Jeanne Marie Evans

Latest:

Manufacturer Reimbursement Support Programs Raise Legal Questions For Specialty Pharmacies

Navigating insurance coverage for specialty drugs has always been a complex and fundamental part of the specialty drug distribution chain.



Guy David, PhD

Latest:

Rheumatoid Arthritis and Joint Replacement: Impact of Biologics

Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.


Shanice Anderson, PharmD Candidate

Latest:

Pursuing a Path With the FDA

As a pharmacy student in Washington DC, I have had the privilege of being exposed to a number of opportunities available for pharmacists who wish to work in the federal government.


Marilyn N. Bulloch, PharmD, BCPS

Latest:

New-Generation Cephalosporins

Since their discovery in the 1950s, cephalosporins have become one of the largest classes of antibiotics.


Shivam Patel, PharmD Candidate

Latest:

Type 3 Diabetes: An Alias for Alzheimer's Disease?

Impairment in insulin and insulin growth factor seems to play a role in the development of Alzheimer's disease.




Stuart Silverman, MD

Latest:

Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition Interactions

This study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.



Tanisha Carino, PhD

Latest:

Patient Engagement and Wellness: A Critical Piece of the Puzzle as Health Care Moves to Value-Based Models

Although we have seen some progress through the proliferation of patient-centered medical homes, most clinicians have not fundamentally altered their basic approach to engaging with their patients.


Stefanie C. Nigro, PharmD, BCACP, CDCES

Latest:

June 2023 Interactive Case Studies

Cases highlight patients who have attention-deficity/hyperactivity disorder and diabetic peripheral nephropathy.


Karen Smith, PharmD, CGP, BCACP

Latest:

Varicella-Zoster Virus: An Ounce of Prevention Does Not Equal a Cure

The impact of varicella-zoster virus vaccination programs on the US population is not yet clear.


Julianne Schlichting

Latest:

Contact Dermatitis

Contact dermatitis is among the most common inflammatory skin conditions encountered by clinicians.



Ilya M. Danelich, PharmD, BCPS

Latest:

Utility of Antithrombotic Therapy in Chronic Systolic Heart Failure

The primary care physician for a 67-year-old female patient with hypertension, dyslipidemia, and chronic non-ischemic systolic heart failure wants to know whether to initiate an antithrombotic agent.


Michelle Woods, American Pharmacy Purchasing Alliance

Latest:

Preventing Medication Errors in Pharmacy

How to avoid common errors in pharmacies to protect patients.


Tara Esse, PharmD, BCACP

Latest:

Medicare Part D Insulin Tiering Change: Impact on Health Outcomes

This study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.


Iris Lin, PhD

Latest:

Annual Stroke Costs to Health Plans Among Atrial Fibrillation Patients

An incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.